Gonorrhea is a sexually transmitted infection (STI) caused by the bacterium Neisseria gonorrhoeae. It is one of the most common STIs in the world, with an estimated 78 million new cases each year. Gonorrhea is spread through sexual contact with someone who has the infection, including oral, vaginal, or anal sex. It can also be passed from mother to child during childbirth. It is important for doctors to understand the risks of gonorrhea so that they can properly diagnose and treat their patients.
Most people with gonorrhea do not experience any symptoms. However, some may experience burning during urination, discharge from the genitals, and pain or swelling in the testicles. Women may experience pain in the lower abdomen, bleeding between periods, and increased vaginal discharge. If left untreated, gonorrhea can cause serious health complications, such as pelvic inflammatory disease, infertility, and ectopic pregnancy.
Gonorrhea is usually diagnosed through a urine test or a swab of the infected area. It is important to note that gonorrhea can be difficult to diagnose, as it does not always cause symptoms. If a person is suspected of having gonorrhea, they should be tested even if they do not have symptoms.
Gonorrhea is treated with antibiotics. It is important to take all of the prescribed medication, even if symptoms have disappeared. It is also important to inform any recent sexual partners so that they can also be tested and treated, if necessary.
The best way to prevent gonorrhea is to practice safe sex, including using condoms or other barrier methods. It is also important to get tested regularly, especially if you are sexually active.
Gonorrhea is a common STI that can cause serious health complications if left untreated. It is important for doctors to understand the risks of gonorrhea so that they can properly diagnose and treat their patients. By practicing safe sex, getting tested regularly, and taking all prescribed medications, people can reduce their risk of contracting and spreading gonorrhea.
1.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
2.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
3.
Recurrent UTIs impact eGFR in children with vesicoureteral reflux
4.
Month-Long Wait Times Caused by US Physician Shortage.
5.
Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.
1.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
2.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
3.
Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice
4.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
5.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation